Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
British Journal of Clinical Pharmacology|June 3, 2015
The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patientsHagen Sjard Bachmann, Werner Meier, Andreas du Bois, et al.Cancer Research|October 26, 2017
A Subpopulation of Stromal Cells Controls Cancer Cell Homing to the Bone MarrowStephanie Rossnagl, Hiba Ghura, Christopher Groth, et al.Molecular Oncology|February 11, 2020
Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cellsMargarita Melnikova, Ulrike Sophie Wauer, Diana Mendus, et al.Frontiers in Pharmacology|February 23, 2023
Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacyClaudia Arndt, Antje Tunger, Rebekka Wehner, et al.Breast Cancer Research : BCR|March 28, 2023
The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudyPauline Wimberger, Jens-Uwe Blohmer, Petra Krabisch, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2023
RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX TrialTheresa Link, Jens-Uwe Blohmer, Wolfgang D Schmitt, et al.Journal of Extracellular Vesicles|October 26, 2018
Precipitation with polyethylene glycol followed by washing and pelleting by ultracentrifugation enriches extracellular vesicles from tissue culture supernatants in small and large scalesAnna-Kristin Ludwig, Kyra De Miroschedji, Thorsten R Doeppner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2022
Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice VariantPauline Wimberger, Mara Julia Gerber, Jacobus Pfisterer, et al.Oncoimmunology|March 28, 2017
Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancerDyah L Dewi, Soumya R Mohapatra, Saioa Blanco Cabañes, et al.Plos Genetics|August 10, 2016
Identification and Functional Testing of ERCC2 Mutations in a Multi-national Cohort of Patients with Familial Breast- and Ovarian CancerAndreas Rump, Anna Benet-Pages, Steffen Schubert, et al.Pageof 6